Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Accounts of Chemical Research
|
March 12, 2026
Upconverting Nanoparticle Thermometry beyond the Diffraction Limit
Benjamin Harrington, Ziyang Ye, Laura Signor, et al.
ACS Nanoscience Au
|
February 26, 2024
Luminescence Thermometry Beyond the Biological Realm
Benjamin Harrington, Ziyang Ye, Laura Signor, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 11, 2005
Effect of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1H)-one (BMS-223131), a novel opener of large conductance Ca2+-activated K+ (maxi-K) channels on normal and stress-aggravated colonic motility and visceral nociception
Digavalli V Sivarao, Kimberly Newberry, Shaun Langdon, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant properties
Svetlana Tertyshnikova, Ronald J Knox, Mary Jane Plym, et al.
Plos One
|
December 21, 2017
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning
Michael R Weed, Joseph Polino, Laura Signor, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine
Guanglin Luo, Ling Chen, Charles M Conway, et al.
Journal of Medicinal Chemistry
|
November 17, 2012
Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine
Guanglin Luo, Ling Chen, Charles M Conway, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2013
Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery
Prasad V Chaturvedula, Stephen E Mercer, Sokhom S Pin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Accounts of Chemical Research
|
March 12, 2026
Upconverting Nanoparticle Thermometry beyond the Diffraction Limit
Benjamin Harrington, Ziyang Ye, Laura Signor, et al.
ACS Nanoscience Au
|
February 26, 2024
Luminescence Thermometry Beyond the Biological Realm
Benjamin Harrington, Ziyang Ye, Laura Signor, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 11, 2005
Effect of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1H)-one (BMS-223131), a novel opener of large conductance Ca2+-activated K+ (maxi-K) channels on normal and stress-aggravated colonic motility and visceral nociception
Digavalli V Sivarao, Kimberly Newberry, Shaun Langdon, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant properties
Svetlana Tertyshnikova, Ronald J Knox, Mary Jane Plym, et al.
Plos One
|
December 21, 2017
Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning
Michael R Weed, Joseph Polino, Laura Signor, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine
Guanglin Luo, Ling Chen, Charles M Conway, et al.
Journal of Medicinal Chemistry
|
November 17, 2012
Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine
Guanglin Luo, Ling Chen, Charles M Conway, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 2, 2013
Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery
Prasad V Chaturvedula, Stephen E Mercer, Sokhom S Pin, et al.
Page
of 1